Valuation: BioHarvest Sciences Inc.

Market Cap 32.87M 28.91M 27.34M 24.79M 46.56M 3.16B 46.83M 327M 126M 1.61B 123M 121M 5.17B P/E 2026 *
-2.75x
P/E 2027 * -4.33x
Enterprise Value 32.87M 28.91M 27.34M 24.79M 46.56M 3.16B 46.83M 327M 126M 1.61B 123M 121M 5.17B EV / Sales 2026 *
0.88x
EV / Sales 2027 * 0.66x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 29/04/2026
Director of Finance/CFO - 28/10/2024
Chief Operating Officer 65 19/04/2023
Director TitleAgeSince
Chairman 68 27/09/2018
Director/Board Member 67 27/09/2018
Director/Board Member 84 07/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 33.1M
+0.92%-1.49%-11.87%-5.57% 13.26B
-0.04%-1.39%-31.78%-57.41% 4.77B
+0.29%-0.70%-4.83%-7.70% 4.29B
+0.07%-2.82%-4.17%-35.42% 3.77B
+0.14%-0.06%-19.70%-3.43% 3.48B
+1.02%-1.20%-0.88%-9.80% 3.35B
+0.88%-1.92%-12.16%-4.96% 3.04B
-0.34%-2.03%-20.76%-19.25% 2.24B
-0.46%-3.07%-25.72%-25.92% 1.64B
Average +0.85%-1.63%-14.65%-18.83% 4.43B
Weighted average by Cap. +0.47%-1.50%-13.62%-16.56%

Financials

2026 *2027 *
Net sales 37.42M 32.91M 31.12M 28.23M 53.01M 3.59B 53.32M 373M 144M 1.83B 140M 137M 5.89B 49.59M 43.61M 41.24M 37.41M 70.25M 4.76B 70.66M 494M 191M 2.43B 186M 182M 7.81B
Net income -12.02M -10.57M -10M -9.07M -17.03M -1.15B -17.13M -120M -46.22M -589M -45.12M -44.15M -1.89B -7.65M -6.73M -6.36M -5.77M -10.83M -734M -10.9M -76.16M -29.41M -375M -28.71M -28.09M -1.2B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.450USD
Average target price
10.50USD
Spread / Average Target
+624.14%

Quarterly revenue - Rate of surprise